APOE and Alzheimer disease: However, few studies have reported a significant hypometabolism in both the ACC and PCC regions in AD (Bailly et al., 2015; Chetelat et al., 2008; Hauser et al., 2013) as well as in apolipoprotein E (APOE) carriers, when compared to noncarriers (Langbaum et al., 2010).